These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26820641)

  • 41. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
    Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.
    Anderegg A; Poulin JF; Awatramani R
    FEBS Lett; 2015 Dec; 589(24 Pt A):3714-26. PubMed ID: 26505674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Orphan nuclear receptor Nurr1 is essential for Ret expression in midbrain dopamine neurons and in the brain stem.
    Wallén A A; Castro DS; Zetterström RH; Karlén M; Olson L; Ericson J; Perlmann T
    Mol Cell Neurosci; 2001 Dec; 18(6):649-63. PubMed ID: 11749040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic control of rodent midbrain dopaminergic neuron development in the light of human disease.
    Klafke R; Wurst W; Prakash N
    Pharmacopsychiatry; 2008 Sep; 41 Suppl 1():S44-50. PubMed ID: 18756420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Environment- and activity-dependent dopamine neurotransmitter plasticity in the adult substantia nigra.
    Aumann TD
    J Chem Neuroanat; 2016 Apr; 73():21-32. PubMed ID: 26718607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mesolimbic dopamine system: evidence for a high amine turnover and for a heterogeneity of the dopamine neuron population.
    Agnati LF; Fuxe K; Andersson K; Benfenati F; Cortelli P; D'Alessandro R
    Neurosci Lett; 1980 May; 18(1):45-51. PubMed ID: 7052480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transmitter release from transplants of fetal ventral mesencephalon or locus coeruleus in the rat frontal cortex and nucleus accumbens: effects of pharmacological and behaviorally activating stimuli.
    Cenci MA; Kalén P; Duan WM; Björklund A
    Brain Res; 1994 Apr; 641(2):225-48. PubMed ID: 8012825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care.
    Trillo L; Das D; Hsieh W; Medina B; Moghadam S; Lin B; Dang V; Sanchez MM; De Miguel Z; Ashford JW; Salehi A
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1363-79. PubMed ID: 23707776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoamine innervation of the forebrain: collateralization.
    Fallon JH; Loughlin SE
    Brain Res Bull; 1982; 9(1-6):295-307. PubMed ID: 6129040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular and cellular determinants for generating ES-cell derived dopamine neurons for cell therapy.
    Pruszak J; Isacson O
    Adv Exp Med Biol; 2009; 651():112-23. PubMed ID: 19731556
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice.
    Le W; Conneely OM; Zou L; He Y; Saucedo-Cardenas O; Jankovic J; Mosier DR; Appel SH
    Exp Neurol; 1999 Oct; 159(2):451-8. PubMed ID: 10506516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease?
    Le Pen G; Sonnier L; Hartmann A; Bizot JC; Trovero F; Krebs MO; Prochiantz A
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S107-11. PubMed ID: 18585951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons.
    Steinkellner T; Zell V; Farino ZJ; Sonders MS; Villeneuve M; Freyberg RJ; Przedborski S; Lu W; Freyberg Z; Hnasko TS
    J Clin Invest; 2018 Feb; 128(2):774-788. PubMed ID: 29337309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Locus coeruleus promotes survival of dopamine neurons in ventral mesencephalon. An in oculo grafting study.
    Berglöf E; Strömberg I
    Exp Neurol; 2009 Mar; 216(1):158-65. PubMed ID: 19150447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Environmental modulations of the number of midbrain dopamine neurons in adult mice.
    Tomas D; Prijanto AH; Burrows EL; Hannan AJ; Horne MK; Aumann TD
    J Vis Exp; 2015 Jan; (95):52329. PubMed ID: 25650697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson's disease.
    Fifel K; Cooper HM
    Neurobiol Dis; 2014 Nov; 71():359-69. PubMed ID: 25171792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopamine acting at D1-like, D2-like and α1-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex.
    Özkan M; Johnson NW; Sehirli US; Woodhall GL; Stanford IM
    PLoS One; 2017; 12(7):e0181633. PubMed ID: 28732063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The functional anatomy of noradrenergic neurons in Parkinson's disease.
    Soldani P; Fornai F
    Funct Neurol; 1999; 14(2):97-109. PubMed ID: 10399622
    [No Abstract]   [Full Text] [Related]  

  • 59. Layer- and area-specific actions of norepinephrine on cortical synaptic transmission.
    Salgado H; Treviño M; Atzori M
    Brain Res; 2016 Jun; 1641(Pt B):163-76. PubMed ID: 26820639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Doping the Mind: Dopaminergic Modulation of Prefrontal Cortical Cognition.
    Ranganath A; Jacob SN
    Neuroscientist; 2016 Dec; 22(6):593-603. PubMed ID: 26338491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.